SELENOP and dementia: In this cohort study, we ascertained baseline biomarkers of selenoprotein P in cerebrospinal fluid and blood of subjects with mild cognitive impairment (MCI) and assessed the extent to which these biomarkers were related to subsequent progression to dementia.